• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2003年至2023年视神经萎缩的文献计量分析:研究趋势与热点

A bibliometric analysis of optic atrophy from 2003 to 2023: research trends and hot spots.

作者信息

Wang Liyuan, Yu Tianyang, Wang Runze, Fu Lijuan, Dong Feixue, Zhao Shuang, Sun He, Gao Yang

机构信息

School of Clinical Medicine, Heilongjiang University of Chinese Medicine, Harbin, China.

Department of Ophthalmology, First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, China.

出版信息

Front Med (Lausanne). 2025 Jan 6;11:1497446. doi: 10.3389/fmed.2024.1497446. eCollection 2024.

DOI:10.3389/fmed.2024.1497446
PMID:39835089
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11743512/
Abstract

BACKGROUND

Optic atrophy (OA) is primarily caused by damage to the retinal pathway system, including widespread degeneration of retinal ganglion cells and axons, leading to visual impairment and blindness. Despite its clinical significance and diverse etiological factors, there is currently a lack of comprehensive bibliometric analyses exploring research trends and hotspots within this field.

METHOD

This study retrieved relevant literature on OA published between 2003 and 2023 from the Web of Science Core Collection database. We conducted a bibliometric analysis using tools such as CiteSpace, VOSviewer, and SCImago Graphica to examine annual publication trends, co-occurrence patterns, collaborative networks among countries and institutions, and the evolution of research hotspots of OA.

RESULTS

A total of 5,274 publications were included in the bibliometric analysis, comprising 4,561 research articles and 713 review articles. The United States emerged as the leading country in OA research, followed by Germany and China. Over the past two decades, the primary research hotspots focused on "mitochondrial dysfunction," "hereditary optic neuropathy," "ocular hypertension" and "diagnostic techniques." Future research trends are likely to revolve around "molecular mechanisms" and "therapeutic targets."

CONCLUSION

This bibliometric analysis provides an overview of research developments in OA over the past 20 years, highlighting the emphasis on the pathological basis of OA and advancements in diagnostic and therapeutic approaches. Future studies should continue to explore the molecular basis of mitochondrial dysfunction to identify potential gene therapy targets for treating OA.

摘要

背景

视神经萎缩(OA)主要由视网膜通路系统受损引起,包括视网膜神经节细胞和轴突的广泛退化,导致视力损害和失明。尽管其具有临床意义且病因多样,但目前缺乏全面的文献计量分析来探索该领域的研究趋势和热点。

方法

本研究从科学网核心合集数据库中检索了2003年至2023年期间发表的关于OA的相关文献。我们使用CiteSpace、VOSviewer和SCImago Graphica等工具进行文献计量分析,以研究OA的年度发表趋势、共现模式、国家和机构之间的合作网络以及研究热点的演变。

结果

文献计量分析共纳入5274篇出版物,其中包括4561篇研究论文和713篇综述文章。美国是OA研究的领先国家,其次是德国和中国。在过去二十年中,主要研究热点集中在“线粒体功能障碍”“遗传性视神经病变”“高眼压症”和“诊断技术”。未来的研究趋势可能围绕“分子机制”和“治疗靶点”展开。

结论

本文献计量分析概述了过去20年OA的研究进展,突出了对OA病理基础的重视以及诊断和治疗方法的进步。未来的研究应继续探索线粒体功能障碍的分子基础,以确定治疗OA的潜在基因治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/144c/11743512/1ae411374ab6/fmed-11-1497446-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/144c/11743512/c37605197a1a/fmed-11-1497446-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/144c/11743512/0a6c49f41be1/fmed-11-1497446-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/144c/11743512/27017d24c71a/fmed-11-1497446-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/144c/11743512/9236aafb13b7/fmed-11-1497446-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/144c/11743512/656db2e74132/fmed-11-1497446-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/144c/11743512/0a7b87190470/fmed-11-1497446-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/144c/11743512/34a837f4f6db/fmed-11-1497446-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/144c/11743512/1ae411374ab6/fmed-11-1497446-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/144c/11743512/c37605197a1a/fmed-11-1497446-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/144c/11743512/0a6c49f41be1/fmed-11-1497446-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/144c/11743512/27017d24c71a/fmed-11-1497446-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/144c/11743512/9236aafb13b7/fmed-11-1497446-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/144c/11743512/656db2e74132/fmed-11-1497446-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/144c/11743512/0a7b87190470/fmed-11-1497446-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/144c/11743512/34a837f4f6db/fmed-11-1497446-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/144c/11743512/1ae411374ab6/fmed-11-1497446-g008.jpg

相似文献

1
A bibliometric analysis of optic atrophy from 2003 to 2023: research trends and hot spots.2003年至2023年视神经萎缩的文献计量分析:研究趋势与热点
Front Med (Lausanne). 2025 Jan 6;11:1497446. doi: 10.3389/fmed.2024.1497446. eCollection 2024.
2
Global research hotspots and trends of theta burst stimulation from 2004 to 2023: a bibliometric analysis.2004年至2023年θ波爆发刺激的全球研究热点与趋势:一项文献计量分析
Front Neurol. 2024 Dec 10;15:1469877. doi: 10.3389/fneur.2024.1469877. eCollection 2024.
3
A bibliometric analysis of light chain amyloidosis from 2005 to 2024: research trends and hot spots.2005年至2024年轻链淀粉样变性的文献计量分析:研究趋势与热点
Front Med (Lausanne). 2024 Jul 30;11:1441032. doi: 10.3389/fmed.2024.1441032. eCollection 2024.
4
Bibliometric analysis of laryngeal cancer treatment literature (2003-2023).喉癌治疗文献的文献计量分析(2003 - 2023年)
Heliyon. 2024 Dec 16;11(1):e40832. doi: 10.1016/j.heliyon.2024.e40832. eCollection 2025 Jan 15.
5
Bibliometric analysis of levosimendan.左西孟旦的文献计量分析
Int J Cardiol Heart Vasc. 2024 Dec 16;56:101571. doi: 10.1016/j.ijcha.2024.101571. eCollection 2025 Feb.
6
Application of artificial intelligence in Alzheimer's disease: a bibliometric analysis.人工智能在阿尔茨海默病中的应用:一项文献计量分析
Front Neurosci. 2025 Feb 14;19:1511350. doi: 10.3389/fnins.2025.1511350. eCollection 2025.
7
Global trends in tumor-associated neutrophil research: a bibliometric and visual analysis.肿瘤相关中性粒细胞研究的全球趋势:文献计量学与可视化分析
Front Immunol. 2025 Mar 14;16:1478092. doi: 10.3389/fimmu.2025.1478092. eCollection 2025.
8
Analyzing the research landscape: Mapping frontiers and hot spots in anti-cancer research using bibliometric analysis and research network pharmacology.分析研究格局:运用文献计量学分析和研究网络药理学绘制抗癌研究的前沿与热点
Front Pharmacol. 2023 Sep 7;14:1256188. doi: 10.3389/fphar.2023.1256188. eCollection 2023.
9
A bibliometric analysis of the application of stem cells in glaucoma research from 1999 to 2022.1999年至2022年干细胞在青光眼研究中应用的文献计量分析
Front Cell Dev Biol. 2023 Jan 18;11:1081898. doi: 10.3389/fcell.2023.1081898. eCollection 2023.
10
A Comprehensive Overview of the Stellate Ganglion Block Throughout the Past Three Decades: A Bibliometric Analysis.过去三十年星状神经节阻滞的全面概述:文献计量分析。
Pain Physician. 2024 Jul;27(5):E597-E610.

本文引用的文献

1
Wolfram Syndrome Type I Case Report and Review-Focus on Early Diagnosis and Genetic Variants.Wolfram 综合征 I 型病例报告及综述——关注早期诊断和遗传变异。
Medicina (Kaunas). 2024 Jun 28;60(7):1064. doi: 10.3390/medicina60071064.
2
Optic Neuropathies: Current and Future Strategies for Optic Nerve Protection and Repair.视神经病变:视神经保护和修复的当前和未来策略。
Int J Mol Sci. 2023 Apr 10;24(8):6977. doi: 10.3390/ijms24086977.
3
Topically Administered NOX4 Inhibitor, GLX7013114, Is Efficacious in Treating the Early Pathological Events of Diabetic Retinopathy.
局部给予的 NOX4 抑制剂 GLX7013114 可有效治疗糖尿病视网膜病变的早期病变事件。
Diabetes. 2023 May 1;72(5):638-652. doi: 10.2337/db22-0515.
4
Mitochondrial optic neuropathies.线粒体视神经病变
Handb Clin Neurol. 2023;194:23-42. doi: 10.1016/B978-0-12-821751-1.00010-5.
5
OCT and OCT Angiography Update: Clinical Application to Age-Related Macular Degeneration, Central Serous Chorioretinopathy, Macular Telangiectasia, and Diabetic Retinopathy.光学相干断层扫描(OCT)与OCT血管造影术的进展:在年龄相关性黄斑变性、中心性浆液性脉络膜视网膜病变、黄斑毛细血管扩张症及糖尿病性视网膜病变中的临床应用
Diagnostics (Basel). 2023 Jan 8;13(2):232. doi: 10.3390/diagnostics13020232.
6
The Past and Present Lives of the Intraocular Transmembrane Protein CD36.眼内跨膜蛋白 CD36 的前世今生。
Cells. 2022 Dec 31;12(1):171. doi: 10.3390/cells12010171.
7
Indirect Comparison of Lenadogene Nolparvovec Gene Therapy Versus Natural History in Patients with Leber Hereditary Optic Neuropathy Carrying the m.11778G>A MT-ND4 Mutation.携带m.11778G>A MT-ND4突变的Leber遗传性视神经病变患者中,利纳基因诺尔帕罗韦克基因疗法与自然病史的间接比较。
Ophthalmol Ther. 2023 Feb;12(1):401-429. doi: 10.1007/s40123-022-00611-x. Epub 2022 Nov 30.
8
Current treatment options for treating -mutant dominant optic atrophy.治疗 - 突变型显性视神经萎缩的现有治疗选择。
Drugs Today (Barc). 2022 Nov;58(11):547-552. doi: 10.1358/dot.2022.58.11.3448291.
9
Pathological mitophagy disrupts mitochondrial homeostasis in Leber's hereditary optic neuropathy.病理性自噬破坏 Leber 遗传性视神经病变中线粒体的动态平衡。
Cell Rep. 2022 Jul 19;40(3):111124. doi: 10.1016/j.celrep.2022.111124.
10
Global Trends and Hotspots in Trigeminal Neuralgia Research From 2001 to 2021: A Bibliometric Analysis.2001年至2021年三叉神经痛研究的全球趋势与热点:一项文献计量分析
Front Neurol. 2022 May 10;13:894006. doi: 10.3389/fneur.2022.894006. eCollection 2022.